Search for:
  • Sign in
  • Register
  • Country Reports
  • Interviews
  • InFocus
  • Europe
  • Asia-Pacific
  • Americas
  • Middle East & Africa
  • Legal & Regulatory
  • Facts & Figures
  • Library
  • Op-eds
  • Shop
Wednesday, June 11, 2025
PharmaBoardroom
Sign In Register
  • Home
  • Country Reports
    • All
    • Americas
    • Asia-Pacific
    • Europe
    • Middle East & Africa
  • Exclusive interviews
    • All
    • Latest
    • Americas
    • Asia-Pacific
    • Europe
    • Middle East & Africa
  • Articles
    • All
    • Global
    • Latest
  • Legal & Regulatory
    • All
    • The Pharma Legal Handbook
    • Regulatory, Pricing and Reimbursement
    • Marketing, Manufacturing, Packaging and Labeling
    • Preclinical and Clinical Trials
  • Op-Eds & Contributions
  • InFigures
    • All
    • Rankings
    • Americas
    • Asia-Pacific
    • Europe
    • Middle East & Africa
  • Library
    • All
    • InFocus
    • InFigures
    • White Papers
  • Media Kit
  • Register
  • About Us
  • Country Reports
  • Interviews
  • InFocus
  • Europe
  • Asia-Pacific
  • Americas
  • Middle East & Africa
  • Legal & Regulatory
  • Facts & Figures
  • Library
  • Op-eds
  • Shop
Brazil Pharma Report 2018 Download

Brazil,

March 2018

With an exit from a period of recession in 2017, a new era of change and positivity is underway in Brazil. Stakeholders from across the public and private sectors are pulling together through strategic partnerships and dialogues to increase both the quantity and quality of the healthcare provided to the 160 million Brazilians who rely on public healthcare as well as the 47 million who are privately insured.

 

Topics covered in this comprehensive report include the opportunities identified by MNCs in Brazil; regulatory upgrades and shifts in government priorities; the strategies and successes of some of Brazil’s standout domestic companies; as well as briefings from across the value chain in areas as diverse as logistics, plastic surgery and homeopathy.

With an exit from a period of recession in 2017, a new era of change and positivity is underway in Brazil. Stakeholders from across the public and private sectors are pulling together through strategic partnerships and dialogues to increase both the quantity and quality of the healthcare provided to the 160 million Brazilians who rely on public healthcare as well as the 47 million who are privately insured.

 

Topics covered in this comprehensive report include the opportunities identified by MNCs in Brazil; regulatory upgrades and shifts in government priorities; the strategies and successes of some of Brazil’s standout domestic companies; as well as briefings from across the value chain in areas as diverse as logistics, plastic surgery and homeopathy.

See more

Legal & Regulatory

report
Buy
Tags:
Brazil, Healthcare, Pharma, Life Sciences, Report,
Share on Facebook Share on WhatsApp Share on Twitter Share on Linkedin Share in Email
Back
PharmaBoardroom

PharmaBoardroom Limited
Evolution House
Iceni Court, Delft Way,
Norwich, NR6 6BB UK

Latest

  • Articles
  • In Conversation
  • Facts & Figures
  • Country Reports
  • Legal & Regulatory
  • InFocus

More

  • About Us

Join Us

  • Email Newsletters
  • LinkedIn

Contact

+44 2078673717

info@stage.pharma.kalyna.dev

Legal & Privacy

  • Terms and Conditions
  • Privacy and Cookies policy
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here

logo

Sign in

Forgot password? Register Now